271 related articles for article (PubMed ID: 33338730)
1. Utility of quantitative ultrasound in community screening for hepatic steatosis.
Chang TY; Chang SH; Lin YH; Ho WC; Wang CY; Jeng WJ; Wan YL; Tsui PH
Ultrasonics; 2021 Mar; 111():106329. PubMed ID: 33338730
[TBL] [Abstract][Full Text] [Related]
2. A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease.
Paige JS; Bernstein GS; Heba E; Costa EAC; Fereirra M; Wolfson T; Gamst AC; Valasek MA; Lin GY; Han A; Erdman JW; O'Brien WD; Andre MP; Loomba R; Sirlin CB
AJR Am J Roentgenol; 2017 May; 208(5):W168-W177. PubMed ID: 28267360
[TBL] [Abstract][Full Text] [Related]
3. Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease.
Ahn JM; Paik YH; Min SY; Cho JY; Sohn W; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Gut Liver; 2016 Mar; 10(2):295-302. PubMed ID: 26347511
[TBL] [Abstract][Full Text] [Related]
4. Validation of fatty liver index and hepatic steatosis index for screening of non-alcoholic fatty liver disease in adults with obstructive sleep apnea hypopnea syndrome.
Chen LD; Huang JF; Chen QS; Lin GF; Zeng HX; Lin XF; Lin XJ; Lin L; Lin QC
Chin Med J (Engl); 2019 Nov; 132(22):2670-2676. PubMed ID: 31765354
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease.
Cen C; Wang W; Yu S; Tang X; Liu J; Liu Y; Zhou L; Yu J; Zheng S
Hepatol Int; 2020 Sep; 14(5):808-816. PubMed ID: 32572817
[TBL] [Abstract][Full Text] [Related]
6. MEASUREMENT OF CONTROLLED ATTENUATION PARAMETER: A SURROGATE MARKER OF HEPATIC STEATOSIS IN PATIENTS OF NONALCOHOLIC FATTY LIVER DISEASE ON LIFESTYLE MODIFICATION - A PROSPECTIVE FOLLOW-UP STUDY.
Paul J; Venugopal RV; Peter L; Shetty KNK; Shetti MP
Arq Gastroenterol; 2018; 55(1):7-13. PubMed ID: 29561981
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive assessment of hepatic steatosis by ultrasound-derived fat fraction in individuals at high-risk for metabolic dysfunction-associated steatotic liver disease.
Tavaglione F; Flagiello V; Terracciani F; Gallo P; Capparelli E; Spiezia C; De Vincentis A; Palermo A; Scriccia S; Galati G; Napoli N; Daniels SJ; Blau JE; Carlsson B; Khazrai YM; Incalzi RA; Picardi A; Vespasiani-Gentilucci U
Diabetes Metab Res Rev; 2024 Mar; 40(3):e3787. PubMed ID: 38461408
[TBL] [Abstract][Full Text] [Related]
8. Hepatic Steatosis Assessment with Ultrasound Small-Window Entropy Imaging.
Zhou Z; Tai DI; Wan YL; Tseng JH; Lin YR; Wu S; Yang KC; Liao YY; Yeh CK; Tsui PH
Ultrasound Med Biol; 2018 Jul; 44(7):1327-1340. PubMed ID: 29622501
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive assessment of paediatric hepatic steatosis by using attenuation imaging.
Hwang SM; Cho KY
Eur Radiol; 2023 Nov; 33(11):8353-8365. PubMed ID: 37195431
[TBL] [Abstract][Full Text] [Related]
10. Interest of hepatic steatosis index (HSI) in screening for metabolic steatopathy in patients with type 2 diabetes.
Fennoun H; Mansouri SE; Tahiri M; Haraj NE; Aziz SE; Hadad F; Hliwa W; Badr W; Chadli A
Pan Afr Med J; 2020; 37():270. PubMed ID: 33598084
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of a novel ultrasound-based quantitative method to assess liver steatosis in histologically identified nonalcoholic fatty liver disease.
Kang KA; Lee SR; Jun DW; Do IG; Kim MS
Med Ultrason; 2023 Mar; 25(1):7-13. PubMed ID: 36780603
[TBL] [Abstract][Full Text] [Related]
12. Visceral adiposity index for the diagnosis of nonalcoholic fatty liver disease in premenopausal women with and without polycystic ovary syndrome.
Vassilatou E; Lafoyianni S; Vassiliadi DA; Ioannidis D; Paschou SA; Mizamtsidi M; Panagou M; Vryonidou A
Maturitas; 2018 Oct; 116():1-7. PubMed ID: 30244768
[TBL] [Abstract][Full Text] [Related]
13. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
[TBL] [Abstract][Full Text] [Related]
14. A prospective comparison of three ultrasound-based techniques in quantitative diagnosis of hepatic steatosis in NAFLD.
Zhu Y; Yin H; Zhou D; Zhao Q; Wang K; Fan Y; Chen K; Han H; Xu H
Abdom Radiol (NY); 2024 Jan; 49(1):81-92. PubMed ID: 37950767
[TBL] [Abstract][Full Text] [Related]
15. CT-based Hounsfield unit values reflect the degree of steatohepatitis in patients with low-grade fatty liver disease.
Kim HN; Jeon HJ; Choi HG; Kwon IS; Rou WS; Lee JE; Lee TH; Kim SH; Lee BS; Shin KS; Lee HJ; Eun HS
BMC Gastroenterol; 2023 Mar; 23(1):77. PubMed ID: 36932382
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter.
Ferraioli G; Calcaterra V; Lissandrin R; Guazzotti M; Maiocchi L; Tinelli C; De Silvestri A; Regalbuto C; Pelizzo G; Larizza D; Filice C
BMC Gastroenterol; 2017 May; 17(1):61. PubMed ID: 28472948
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic fatty liver disease (NAFLD) detection and deep learning in a Chinese community-based population.
Yang Y; Liu J; Sun C; Shi Y; Hsing JC; Kamya A; Keller CA; Antil N; Rubin D; Wang H; Ying H; Zhao X; Wu YH; Nguyen M; Lu Y; Yang F; Huang P; Hsing AW; Wu J; Zhu S
Eur Radiol; 2023 Aug; 33(8):5894-5906. PubMed ID: 36892645
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM Study.
Lemoine M; Assoumou L; De Wit S; Girard PM; Valantin MA; Katlama C; Necsoi C; Campa P; Huefner AD; Schulze Zur Wiesch J; Rougier H; Bastard JP; Stocker H; Mauss S; Serfaty L; Ratziu V; Menu Y; Schlue J; Behrens G; Bedossa P; Capeau J; Ingiliz P; Costagliola D;
J Acquir Immune Defic Syndr; 2019 Apr; 80(4):e86-e94. PubMed ID: 30570529
[TBL] [Abstract][Full Text] [Related]
19. How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound.
Carvalhana S; Leitão J; Alves AC; Bourbon M; Cortez-Pinto H
Liver Int; 2014 Jul; 34(6):e111-7. PubMed ID: 24034415
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of a noninvasive hepatic ultrasound score for non-alcoholic fatty liver disease (NAFLD) in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
Goulart AC; Oliveira IR; Alencar AP; Santos MS; Santos IS; Martines BM; Meireles DP; Martines JA; Misciagna G; Benseñor IM; Lotufo PA
Sao Paulo Med J; 2015; 133(2):115-24. PubMed ID: 26018881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
